P Borgeat

6.7k citations

121 papers · 5.6k indexed · 4 hit papers · h-index 35

Impact in

Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology
Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization

Papers in

Biochemistry 22
- Eicosanoids and Hypertension Pharmacology 21
Physiology 48
- Asthma and respiratory diseases 39

Co-authors: Bengt Samuelsson Paul H. Naccache Mats Hámberg R.I. Sha’afi Patrice E. Poubelle Pierré Sirois Thaddeus F. Molski Sven Hammarström
Journals: Prostaglandins (12 papers)The Journal of Immunology (10 papers)Journal of Biological Chemistry (6 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)Inflammation Research (4 papers)
Partner nations: Canada United States France

In The Last Decade

P Borgeat

121 papers receiving 5.2k citations

Hit Papers

align trajectories log scale

Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids. 1979 · 368 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1979 Proceedings of the National Academy of Sciences
1979 Journal of Biological Chemistry
1979 Journal of Biological Chemistry
1976 Journal of Biological Chemistry

Peers

Countries citing papers authored by P Borgeat

Since Specialization

Citations

This map shows the geographic impact of P Borgeat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Borgeat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Borgeat more than expected).

Fields of papers citing papers by P Borgeat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Borgeat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Borgeat. The network helps show where P Borgeat may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P Borgeat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P Borgeat Line = papers co-authored together P Borgeat links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of pyrrophenone, an inhibitor of group IVA phospholipase A₂, on eicosanoid and PAF biosynthesis in human neutrophils British Journal of Pharmacology ·Nicolas Flamand, Serge Picard, Louis Lemieux, Marc Pouliot, Sylvain Bourgoin, P Borgeat	2006	27
2	Adenosine A₂receptor‐induced inhibition of leukotriene B₄synthesis in whole bloodex vivo British Journal of Pharmacology ·Éric Krump, Geneviève Lemay, P Borgeat	1996	43
3	Superantigen-induced collagenase gene expression in human IFN-γ-treated fibroblast-like synoviocytes involves prostaglandin E2. Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2 The Journal of Immunology ·K Mehindate, Reem Al‐Daccak, J.-M. Dayer, Brian P. Kennedy, Yajie Gu, P Borgeat, Patrice E. Poubelle, Walid Mourad	1995	46
4	BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils. Journal of Pharmacology and Experimental Therapeutics ·Peter R. Farina, Anne G. Graham, Ann F. Hoffman, Michelle F. Bissonnette, P Borgeat, M. Nadeau, David Bath, Dominikus B nsch, Jerry L. Adams, Changqing Miao	1994	5
5	Highly purified guinea pig type II pneumocytes have the leukotriene A4 hydrolase but do not express 5-lipoxygenase activity Prostaglandins Leukotrienes and Essential Fatty Acids ·A Gulevatenko, Karim Maghni, Jocelyn Laporte, 末永香菜美, Vijayakumar H Doddamanl, P Borgeat, Pierré Sirois	1994	4
6	Reverse-Phase High-Performance Liquid Chromatography Analysis of Arachidonic Acid Metabolites in Plasma after Stimulation of Whole Blood ex Vivo Analytical Biochemistry ·Marc E. Surette, Yudo Tri Anggoro, Rémi Palmantier, Sylvie Marleau, Patrice E. Poubelle, P Borgeat	1994	31
7	Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: involvement of the CD14 antigen. The Journal of Experimental Medicine ·Marc E. Surette, Rémi Palmantier, Jean Gosselin, P Borgeat	1993	90
8	Leukotriene B4 receptors on guinea pig alveolar eosinophils. Journal of Pharmacology and Experimental Therapeutics ·Karim Maghni, Artur J. de Brum‐Fernandes, Éva Földes‐Filep, Muriel Gaudry, P Borgeat, Pierré Sirois	1991	29
9	Purification of natural killer-like Kurloff cells and arachidonic acid metabolism Prostaglandins ·Karim Maghni, A Gulevatenko, Jocelyn Laporte, Vijayakumar H Doddamanl, P Borgeat, Hon. Antonin Scalia	1991	4
10	Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole bloodex vivo Inflammation Research ·Pierré Sirois, P Borgeat, Francesca Giuliani, Louise M. Dubé, Paul Rubin, J. W. Kesterson	1991	30
11	Metabolism of arachidonic acid by guinea pig Clara cells Prostaglandins ·Jocelyn Laporte, Vijayakumar H Doddamanl, Karim Maghni, A Gulevatenko, P Borgeat, Pierré Sirois	1991	7
12	Involvement of a phospholipase D in the mechanism of action of granulocyte-macrophage colony-stimulating factor (GM-CSF): priming of human neutrophils in vitro with GM-CSF is associated with accumulation of phosphatidic acid and diradylglycerol. The Journal of Experimental Medicine ·Sylvain Bourgoin, Albinali KE, Muriel Gaudry, Paul H. Naccache, P Borgeat, Patrice E. Poubelle	1990	70
13	Guinea pig alveolar eosinophils and macrophages produce leukotriene B4 but no peptido-leukotriene. The Journal of Immunology ·K. Hirata, Karim Maghni, P Borgeat, Pierré Sirois	1990	28
14	Granulocyte-macrophage colony-stimulating factor (GM-CSF) and opsonization synergistically enhance leukotriene B4 (LTB4) synthesis induced by phagocytosis in human neutrophils Inflammation Research ·Patrice E. Poubelle, Sylvain Bourgoin, Paul H. Naccache, P Borgeat	1989	15
15	Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages. The Journal of Immunology ·Michel Laviolette, Madeleine Carreau, Roger A. Coulombe, Irene M. Kaales, R. E. Sieck, W. Zubke, P. Braquet, P Borgeat	1988	17
16	Calcium mobilization, actin polymerization and right-angle light scatter responses to leukotriene B4, 12(R)- and 12(S)-hydroxyeicosatetraenoic acid in human neutrophils Life Sciences ·Paul H. Naccache, Suddamalla Maneesha, XU Quan-zhe, P Borgeat	1988	22
17	Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils. The Journal of Immunology ·Paul H. Naccache, Suddamalla Maneesha, P Borgeat, Judith C. Gasson, John F. DiPersio	1988	73
18	A comparative study of methyl ester trimethylsilyl, allyldimethylsilyl andtert-butyldimethylsilyl ethers for electron impact mass spectrometry of leukotrienes Journal of Mass Spectrometry ·Edward Coventry, P Borgeat, Michael J. Evans, Michel Bertrand	1987	13
19	Role of Cyclooxygenase Products in the Lung Action of Leukotrienes A<sub>4</sub>, B<sub>4</sub>, C<sub>4</sub>, D<sub>4</sub> and E<sub>4</sub> Pharmacology ·Pierré Sirois, Marie‐Christine Chagnon, P Borgeat, Pierre Vallerand	1985	15
20	Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate. The Journal of Experimental Medicine ·H. Salari, P Borgeat, Michel Fournier, Jean‐Louis Hébert, Geneviève Pelletier	1985	41

About P Borgeat

P Borgeat is a scholar working on Biochemistry, Physiology, Immunology and Allergy, Immunology and Pharmacology, having authored 121 papers that have together received 5.6k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (39 papers), Immune Response and Inflammation (26 papers), Eicosanoids and Hypertension Pharmacology (21 papers), Inflammatory mediators and NSAID effects (20 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (18 papers), S100 Proteins and Annexins (14 papers), Respiratory and Cough-Related Research (13 papers) and Analytical Chemistry and Chromatography (6 papers). The work is most often cited by research in Biochemistry (952 citations), Immunology and Allergy (546 citations), Immunology (1.7k citations), Physiology (2.0k citations) and Pharmacology (1.3k citations). P Borgeat has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Bengt Samuelsson, Paul H. Naccache, Mats Hámberg, R.I. Sha’afi, Patrice E. Poubelle, Pierré Sirois, Thaddeus F. Molski, Sven Hammarström, Serge Picard and John R. White. Their work appears in journals such as Prostaglandins, The Journal of Immunology, Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics and Inflammation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact